Diagnostics featured in global access report
This article was originally published in Clinica
Executive Summary
The twin hurdles of unaffordability and a paucity of information on competitive products are depriving developing countries from accessing the medical technologies they need to tackle infectious diseases and improve therapy monitoring. This is the reasoning behind the fourth annual update of the report Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS, published last week.